Skip to content

Howie Roseman discusses Brandon Brooks’ status with the Eagles

Since the start of the season, the Eagles have provided very little news regarding All-Pro guard Brandon Brooks. During their week two game against the San Francisco 49ers, Brooks suffered a pectoral injury and was shut down for the remainder of the season. 

Over the last few days, there have been rumors that Brooks could retire, but they doesn’t seem legitimate at all. Brooks has three years remaining on his contract totaling $42 million, so it’s highly doubtful he would walk away from all that money. 

During their end-of-the-season press conference, Howie Roseman and Nick Sirianni were asked about Brooks’ status and his future with the team, and their response wasn’t the greatest.

Brooks has likely played his final snaps with the Eagles, playing just one full game over the last two seasons. Philadelphia has numerous starting-caliber guards, including Nate Herbig, Sua Opeta, and Landon Dickerson.  

Herbig is currently a free agent, and the Eagles won’t pay both him and Brooks with their limited cap space. Roseman tried to trade Brooks before the start of the season, but trade discussions never picked up.

With a loaded depth chart and a need to spend their money elsewhere, Brooks has quickly found himself as the odd man out. Due to his contract and injury history, it’s hard to imagine teams would pay more than a day-three pick for a 32-year-old with two torn Achilles.

Several moves could be on the horizon for the Eagles’ offensive line this offseason. Jason Kelce is another free agent, and he’s been known to contemplate retirement for several seasons now and the Eagles could target someone like Tyler Linderbaum during the upcoming NFL Draft.

Mandatory Credit: NFL Trade Rumors

Writer for The Liberty Line, Host of The Flyover Podcast. You can follow me on Twitter @JackPConnell

This Post Has 0 Comments

Leave a Reply

Back To Top

Discover more from The Liberty Line

Subscribe now to keep reading and get access to the full archive.

Continue reading